Outsourcing Pharma
MARCH 1, 2024
a prominent figure in metabolomics solutions, has launched a seminal integrated bioinformatics platform, aiming to redefine metabolomics analysis in life sciences research. Metabolon, Inc.,
The Pharma Data
MARCH 2, 2021
This new collaboration builds on the positive experience from previous partnerships with Gubra and combines Gubra’s proprietary streaMLine platform and expertise in obesity and peptide chemistry with Boehringer Ingelheim’s expertise in lead optimization and clinical development. Financial terms of the new agreement are not disclosed.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Drug Discovery World
APRIL 29, 2024
Scott Kobayashi, Senior Vice President of Sales, BioPhy: Kobayashi previously founded Delta Project Management, a life sciences consulting firm he sold to Versita in 2022, and held consulting roles with companies like Pfizer, Genentech, and Flour. He has a PhD in Bioinformatics from the University of Cambridge.
XTalks
SEPTEMBER 5, 2023
Xtalks spoke with Maria Reyes Boceta-Muñoz, Clinical Operations Head of Development R&D at GlaxoSmithKline in Spain, Portugal & Israel, to understand the current vaccine development climate and where the sector is headed.
Drug Discovery World
NOVEMBER 13, 2023
Novel/alternative ML-enabled screening technologies for higher POS Following chairperson’s remarks from M Frank Erasmus, PhD, Head, Bioinformatics, Specifica, there will be four presentations and a panel discussion. It is called, ‘An unexpected future for immune oncology therapies?’
Drug Discovery World
NOVEMBER 30, 2023
Field also covered the capabilities and strategies that enable acceleration of Fc-fusion, Fab fragment and bispecific antibodies through pre-clinical development. It was presented by Xiaole Shirley Liu, PhD, CEO, GV20 Therapeutics, and titled: ‘AI-based target and antibody discovery from patient tumour profiles’.
Expert insights. Personalized for you.
102 
Let's personalize your content